Gene · 1999
Papers2,176
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,176
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heterogeneous Radioimmunotherapy for Bulky Tumors: A Phase 1 Trial for Advanced Non-Small Cell Lung Cancer. | Adv Radiat Oncol | 2026 | 42824609 | PubTator, text mining | PubMed |
| Oral Actinobacteria sense and defend against parasitic epibionts. | bioRxiv | 2026 | 42818358 | PubTator, text mining | PubMed |
| Mapping Mutations and Signaling Network Interactions to Guide Precision Therapy in Gallbladder Cancer. | Cancer Rep (Hoboken) | 2026 | 42817222 | PubTator, text mining | PubMed |
| Episodic Future Thinking: A Behavioral Intervention to Promote Weight Loss in Breast Cancer Survivors (Alliance A21-Pilot10). | JCO Oncol Adv | 2026 | 42808090 | PubTator, text mining | PubMed |
| A canonical role of SMAD4 in safeguarding 3D genome architecture to suppress lung tumorigenesis. | Oncogene | 2026 | 42760353 | PubTator, text mining | PubMed |
| Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer. | Clin Cancer Res | 2026 | 42720429 | PubTator, text mining | PubMed |
| A reproducible epithelial transcriptional state combines interferon-associated and secretory programs in pancreatic ductal adenocarcinoma. | Front Genet | 2026 | 42656570 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis identifies an enhancer-driven ELF3-CLDN4 regulatory axis that shapes an immunosuppressive microenvironment and predicts prognosis in high-grade serous ovarian cancer. | Gene | 2026 | 42624178 | PubTator, text mining | PubMed |
| Construction and validation of a nomogram for the diagnosis of postmenopausal osteoporosis. | Mol Med Rep | 2026 | 42596822 | PubTator, text mining | PubMed |
| Super enhancer-driven transcriptional reprogramming promotes abiraterone resistance via neuroendocrine transition and ferroptosis evasion in castration-resistant prostate cancer. | Oncogene | 2026 | 42527507 | PubTator, text mining | PubMed |
| ELF3 links kidney function GWAS loci to maladaptive epithelial inflammation. | Sci Adv | 2026 | 42497247 | PubTator, text mining | PubMed |
| ELF-3 and TSC-1 as potential markers of recurrence in low-risk non-muscle-invasive bladder cancer. | BMC Cancer | 2026 | 42321663 | PubTator, text mining | PubMed |
| Establishment of an N-Glycan Profiling Method for Three ERT Enzymes Used in Gaucher Disease Therapy. | Molecules | 2026 | 42280207 | PubTator, text mining | PubMed |
| Growth Patterns in MPS IVA and MPS IIIA: A Longitudinal Single-Center Study. | J Clin Med | 2026 | 42279040 | PubTator, text mining | PubMed |
| USP18-stabilized ELF3 drives glycolysis and malignant progression in lung adenocarcinoma. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 42212622 | PubTator, text mining | PubMed |
| Discovery of a Small-Molecule Inhibitor Targeting the ELF3-HSP27 Interaction to Suppress Breast Cancer Progression. | Pharmaceuticals (Basel) | 2026 | 42198413 | PubTator, text mining | PubMed |
| Urinary exosomes in diabetic kidney disease: Pathophysiological insights and diagnostic potential. | Life Sci | 2026 | 42176882 | PubTator, text mining | PubMed |
| Geographic and genetic diversity in gallbladder cancer mutation profiles: insights from a worldwide exome analysis. | EBioMedicine | 2026 | 42167123 | PubTator, text mining | PubMed |
| New Insights into the Development of Papillary Thyroid Cancer: The Roles of miR-1179 and ELF3. | Cells | 2026 | 42121903 | PubTator, text mining | PubMed |
| Intratumor heterogeneity in human basal like breast cancer is revealed by single cell molecular subtyping. | Commun Med (Lond) | 2026 | 41975055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1999/papers